Revolutionizing Cancer Treatment
The Power of Molecularly Imprinted Polymers for Precision Therapy
- 1st Edition - April 1, 2026
- Latest edition
- Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Anand Krishnan, Rishabha Malviya
- Language: English
Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy offers an in-depth exploration on how molecularly imprinted polymers (MIPs)… Read more
Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy offers an in-depth exploration on how molecularly imprinted polymers (MIPs) are transforming cancer therapy. Addressing the growing need for precision medicine, this book examines the development of advanced drug delivery systems that target specific cancer types, including breast, prostate, and lung cancers. By bridging molecular imprinting techniques with precision oncology, the guide provides practical insights for researchers, clinicians, and pharmaceutical professionals eager to improve the specificity and efficacy of cancer treatments while minimizing unwanted side effects.
Each chapter focuses on a particular cancer type, detailing how MIPs are designed and applied in targeted therapies. The inclusion of flow charts, process diagrams, and case studies simplifies complex scientific concepts, making the content valuable for students, academics, and healthcare professionals. As a much-needed resource, it fills a literature gap by clearly outlining the clinical and research applications of MIPs in cancer management.
Each chapter focuses on a particular cancer type, detailing how MIPs are designed and applied in targeted therapies. The inclusion of flow charts, process diagrams, and case studies simplifies complex scientific concepts, making the content valuable for students, academics, and healthcare professionals. As a much-needed resource, it fills a literature gap by clearly outlining the clinical and research applications of MIPs in cancer management.
- Focuses on many distinct cancer types (e.g., breast, prostate, pancreatic, lung), detailing how molecularly imprinted polymers (MIPs) can be tailored for drug delivery and treatment
- Provides a solid foundation on the principles and latest advancements of this technology, addressing challenges and opportunities
- Emphasizes how MIPs can serve as precision tools in cancer therapy
- Delves into various molecular imprinting methods used to develop MIPs-based drug delivery systems
Researchers and students in the fields of pharmaceutical sciences, oncology, and biomedical engineering
1. Introduction
2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer
3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.
4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.
5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.
6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.
7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.
8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.
9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.
10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.
11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.
12. Molecularly imprinted polymers as precision tools in cancer
2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer
3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.
4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.
5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.
6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.
7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.
8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.
9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.
10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.
11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.
12. Molecularly imprinted polymers as precision tools in cancer
- Edition: 1
- Latest edition
- Published: April 1, 2026
- Language: English
BP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, where he has served since September 2010. He holds a B.Pharm from the University of Rajasthan and an M.Pharm in Pharmaceutics from Rajasthan University of Health Sciences, along with a PhD in pharmaceutical sciences. With 14 years of teaching and administrative experience, Dr. Kapoor has authored over 35 research and review articles in esteemed national and international journals and contributed to several books published by Elsevier, Bentham Science, MDPI, Springer, and Wiley. His research focuses on osmotic drug delivery systems, solid lipid nanoparticles, and microspheres. He has received significant grants for organizing national seminars and faculty development programs. Dr. Kapoor holds three design patents and has delivered over 10 expert talks at various national conferences. He is currently the editor of three international books with prominent publishers.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, IndiaAK
Anand Krishnan
Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaRM
Rishabha Malviya
Rishabha Malviya, did his PhD (Pharmacy) work in the area of novel formulation development techniques. He has 12 years of research experience and presently works as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of research interest includes formulation optimization, nano formulation, nanorobotic targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical drugs. He has authored more than 200 research/review papers for national/international journals of repute. He has 51 patents and has received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing more than 70 books (Wiley, CRC Press, Springer Nature, River Publishers, De Gryuter, IOP publishing, Nova Science Publishers and Apple Academic Press) and authored 125 book chapters. His name is included in the world's top 2% of scientists in 2020, 2021 and 2022 by Elsevier and Stanford University.
Affiliations and expertise
Galgotias University, India